报价延迟最少15分钟:2026/11/08 00:44 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.3728 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.36/--
|
|
企业价值
11.94M
|
| 资产负债 |
|
每股账面净值
0.20
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
5.85M
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis. |
